Teleflex Incorporated (TFX)
| Market Cap | 11.69B |
| Revenue (ttm) | 2.79B |
| Net Income (ttm) | 363.14M |
| Shares Out | 46.94M |
| EPS (ttm) | 7.68 |
| PE Ratio | 32.41 |
| Forward PE | 22.27 |
| Dividend | $1.36 (0.55%) |
| Ex-Dividend Date | Mar 2, 2023 |
| Volume | 288,088 |
| Open | 241.01 |
| Previous Close | 241.34 |
| Day's Range | 239.28 - 249.15 |
| 52-Week Range | 182.65 - 356.72 |
| Beta | 0.97 |
| Analysts | Buy |
| Price Target | 269.67 (+8.33%) |
| Earnings Date | Apr 27, 2023 |
About TFX
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional prod... [Read more]
Financial Performance
In 2022, Teleflex's revenue was $2.79 billion, a decrease of -0.66% compared to the previous year's $2.81 billion. Earnings were $363.14 million, a decrease of -25.18%.
Financial StatementsAnalyst Forecast
According to 19 analysts, the average rating for TFX stock is "Buy." The 12-month stock price forecast is $269.67, which is an increase of 8.33% from the latest price.
News
UroLift® System Research Data from EAU Highlight Durability and Superior Patient Experience, Along with Benefits of Earlier Treatment for BPH
Presentations at the 38th Annual European Association of Urology Congress Reinforce Low Surgical Retreatment of the UroLift® System
Teleflex to Present at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum: Virtual
WAYNE, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Capital Mark...
Teleflex (TFX) Q4 Earnings Top Estimates, Operating Margin Down
Teleflex (TFX) revenues in Asia rise backed by strong contributions from growth in all geographies.
Teleflex (TFX) Surpasses Q4 Earnings Estimates
Teleflex (TFX) delivered earnings and revenue surprises of 2.33% and 0.31%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Teleflex Announces Quarterly Dividend
WAYNE, Pa., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of...
Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results
WAYNE, Pa., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2022.
Teleflex Expands Interventional Cardiology Portfolio with Two New FDA-Cleared Catheter Devices for Use in Complex Percutaneous Coronary Interventions (PCI)
Triumph™ Catheter and GuideLiner® Coast™ Catheter to be featured at the CTO Plus Conference, February 23-24 in New York, NY Triumph™ Catheter and GuideLiner® Coast™ Catheter to be featured at the CTO ...
Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference
WAYNE, Pa., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 44th Annual Raymond James Institutional Investors...
Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information
WAYNE, Pa., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m...
Standard Bariatrics, Inc., now part of Teleflex, Awarded Bariatric Stapling Technology Agreement with Premier Inc.
WAYNE, Pa., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded a group purchasing organization (GPO)...
Teleflex Launches National Ad Campaign — “Pit Stop” — to Raise Awareness of the UroLift® System as a Treatment for Enlarged Prostate
The campaign drives education about the importance of regular health screenings and treatment options for benign prostatic hyperplasia (BPH), a common men's health condition. The campaign drives educa...
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated
NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors' and officers' possible viola...
Will Teleflex (TFX) Beat Estimates Again in Its Next Earnings Report?
Teleflex (TFX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Hold on to Teleflex (TFX) Stock for Now
Investors are optimistic about Teleflex (TFX) on strong preference for the UroLift system.
Teleflex (TFX) OEM Arm Grows, Supply Issue Persists
From a geographic perspective, Teleflex (TFX) is seeing strong results in Asia, which continues to be an important growth driver for Teleflex.
Teleflex to Present at the 41st Annual J.P. Morgan Healthcare Conference
WAYNE, Pa., Dec. 27, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 41st Annual J.P. Morgan Healthcare Conference at ...
Teleflex Celebrates 400,000 Patients Treated With the Minimally Invasive UroLift® System
WAYNE, Pa., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that 400,000 patients have now been treated with the...
Should You Buy Teleflex Stock At $225?
Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, dow...
Teleflex Earns Top Spot in MedReps Best Places to Work 2023 Ranking
WAYNE, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced it was named a MedReps.com 2023 Best Places to W...
Teleflex to Present at the 34th Annual Piper Sandler Healthcare Conference
WAYNE, Pa., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 34th Annual Piper Sandler Healthcare Conference a...
Teleflex Announces Worldwide Recall of Gibeck® Iso-Gard® Filter
WAYNE, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced a worldwide recall of af...
U.S. FDA classifies recall of Teleflex's respiratory filters as most serious
U.S. health regulators on Tuesday classified the recall of Teleflex Inc's Iso-Gard filter S, a medical device to protect patients from potential airborne contaminants, as most serious, saying its use ...
Teleflex (TFX) Q3 Earnings Top Estimates, Adjusted EPS View Cut
For UroLift, Teleflex (TFX) currently assumes 2022 revenues to be roughly $320 million, down from the prior guidance of $335 million.
Teleflex to Present at the Jefferies London Healthcare Conference
WAYNE, Pa., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Jefferies London Healthcare Conference, on Tuesda...
Teleflex (TFX) Surpasses Q3 Earnings Estimates
Teleflex (TFX) delivered earnings and revenue surprises of 5.48% and 0.65%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?